This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Talmadge, J. E. Articles by Liggitt, D. Search for Related Content PubMed PubMed Citation Articles by Talmadge, J. E. Articles by Liggitt, D.

American Journal of Pathology, Vol 128, 410-425, Copyright © 1987 by American Society for Investigative Pathology

REGULAR ARTICLES

Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors

JE Talmadge, O Bowersox, H Tribble, SH Lee, HM Shepard and D Liggitt

In recent studies, we have demonstrated that recombinant human tumor necrosis factor (rH TNF), as a single agent, has only minimal therapeutic activity for the treatment of metastatic disease, but when combined with recombinant murine gamma-interferon (rM gamma-IFN), we observed significantly more therapeutic activity than when either agent was administered alone. However, this combination also resulted in increased toxicity. Thus, we undertook a systematic toxicologic study of rH TNF alone or in combination with rM gamma-IFN. Briefly, the toxicity was similar to the generalized Shwartzman's reaction seen during endotoxin shock, with multifocal microthrombi and ischemic necrosis as sequelae. Lesions were observed in the lungs, liver, gastrointestinal tract (preferentially in the duodenum and cecum), testes or uterus, and bone marrow. Our results suggest that TNF (either directly administered or induced in situ) and its induction of arachidonic acid metabolites form one element of toxicity in this model. This conclusion is supported by studies revealing that the toxicity of rH TNF in combination with rM gamma-IFN can be reduced by inhibitors of the cyclooxygenase/lipoxygenase pathway.

This article has been cited by other articles:

				S.J. HACKETT, A.P. J. THOMSON, and C.A. HART Cytokines, chemokines and other effector molecules involved in meningococcal disease J. Med. Microbiol., October 1, 2001; 50(10): 847 - 859. [Abstract] [Full Text] [PDF]

				M. M. Dinges and P. M. Schlievert Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice Infect. Immun., March 1, 2001; 69(3): 1256 - 1264. [Abstract] [Full Text] [PDF]

				T. Nishimura and A. Ohta A Critical Role for Antigen-Specific Th1 Cells in Acute Liver Injury in Mice J. Immunol., June 1, 1999; 162(11): 6503 - 6509. [Abstract] [Full Text] [PDF]

				D. Veloso, S. Denny, T.M. Cosgriff, and H.D. Hochstein Differential susceptibility of rhesus monkeys to high doses of endotoxin Innate Immunity, December 1, 1995; 2(6): 411 - 420. [Abstract] [PDF]